Dimebon attenuates the Aβ-induced mitochondrial permeabilization

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• The neuroprotective effects of dimebon are hypothesized to involve protection of brain mitochondria.
• Understanding dimebon's influence on mitochondrial function is crucial for elucidating its therapeutic potential.

Purpose of the Study:

• To investigate the influence of dimebon on isolated rat brain and liver mitochondria.
• To understand dimebon's role in mitochondrial permeability transition (MPT) and calcium retention capacity (CRC).

Main Methods:

• Isolated rat brain and liver mitochondria were used.
• Mitochondrial permeability transition (MPT) was induced by calcium ions and atractyloside.
• Calcium retention capacity (CRC) was measured using three different assays.
• Amyloid-beta peptide was used to induce mitochondrial toxicity.

Main Results:

• Dimebon enhanced mitochondrial resistance to calcium-induced MPT, but not swelling, in the presence of atractyloside.
• Dimebon did not inhibit MPT in de-energized mitochondria or affect adenine nucleotide translocase (ANT) conformational changes, unlike cyclosporine A.
• Dimebon's effect on CRC depended on calcium addition mode, increasing CRC in bolus mode and prolonging calcium efflux lag time.
• Dimebon effectively counteracted amyloid-beta-induced mitochondrial swelling and decreased CRC.

Conclusions:

• Dimebon protects brain mitochondria against amyloid-beta toxicity by modulating calcium handling.
• Dimebon's mechanism differs from classical MPT inhibitors like CsA.
• These findings support dimebon's potential as a neuroprotective agent against mitochondrial dysfunction in neurodegenerative diseases.